Ke Cheng Selected Research

Ke Cheng Research Topics

Disease

48	Neoplasms (Cancer) 02/2024 - 09/2005
39	Myocardial Infarction 09/2023 - 05/2010
19	Inflammation (Inflammations) 01/2023 - 12/2011
15	Infections 12/2023 - 08/2005
12	Fibrosis (Cirrhosis) 01/2024 - 08/2015
12	Pain (Aches) 03/2022 - 01/2010
11	Infarction (Infarctions) 01/2020 - 03/2012
10	Knee Osteoarthritis 11/2023 - 01/2010
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
8	COVID-19 03/2024 - 01/2021
8	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2013
7	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 07/2014
6	Cicatrix (Scar) 11/2020 - 03/2012
6	Myocardial Ischemia (Ischemic Heart Diseases) 04/2020 - 10/2014
5	Adenocarcinoma 04/2024 - 01/2020
5	Heart Failure 10/2022 - 03/2012
5	Pneumonia (Pneumonitis) 01/2022 - 10/2017
5	Cardiomyopathies (Cardiomyopathy) 10/2017 - 04/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2022
4	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 10/2020
4	Heart Diseases (Heart Disease) 01/2021 - 08/2015
4	Insulin Resistance 01/2020 - 05/2015
4	Ventricular Remodeling 01/2019 - 12/2011
4	Carcinogenesis 01/2018 - 09/2005
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017 - 01/2015
3	Wounds and Injuries (Trauma) 10/2023 - 02/2019
3	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2013
3	Hypoxia (Hypoxemia) 01/2023 - 01/2021
3	Fatigue 11/2022 - 12/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2010
3	Reperfusion Injury 10/2021 - 01/2012
3	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 01/2018
3	Schizophrenia (Dementia Praecox) 01/2021 - 01/2019
3	Osteoarthritis 04/2020 - 01/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 06/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 11/2015
3	Ischemia 01/2019 - 01/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2016 - 01/2013
2	Virus Diseases (Viral Diseases) 03/2024 - 06/2021
2	Bacterial Infections (Bacterial Infection) 01/2024 - 01/2023
2	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2017
2	Hepatitis B 11/2023 - 02/2021
2	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 01/2023
2	Demyelinating Diseases (Demyelinating Disease) 03/2023 - 01/2017
2	Depressive Disorder (Melancholia) 01/2023 - 12/2015

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2005
14	salicylhydroxamic acid (SHAM)IBA 11/2023 - 01/2010
14	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2017 - 03/2012
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2014
8	Long Noncoding RNAIBA 03/2024 - 01/2018
7	Gemcitabine FDA Link 03/2023 - 01/2012
7	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2020
5	130-nm albumin-bound paclitaxelIBA 03/2023 - 01/2020
5	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2020
4	VaccinesIBA 03/2024 - 04/2011
4	Therapeutic UsesIBA 10/2023 - 09/2014
4	HydrogelsIBA 07/2023 - 01/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2005
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 10/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 12/2010
4	raltitrexed (D 1694)IBA 01/2022 - 10/2013
4	Biocompatible Materials (Biomaterials)IBA 07/2021 - 12/2011
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2013
3	IronIBA 02/2024 - 05/2010
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2020
3	MicrogelsIBA 10/2023 - 01/2018
3	toripalimabIBA 03/2023 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2023 - 07/2014
3	CytokinesIBA 01/2023 - 01/2020
3	Oxygen (Dioxygen)IBA 01/2023 - 01/2011
3	NAD (NADH)IBA 01/2022 - 10/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 08/2018
3	PolymersIBA 03/2021 - 01/2017
3	FibrinIBA 01/2021 - 06/2016
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
3	Cholecalciferol (Vitamin D3)FDA Link 05/2020 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 11/2015
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 09/2013
3	NucleophosminIBA 04/2010 - 09/2005
2	palbociclibIBA 04/2024 - 01/2023
2	AntioxidantsIBA 02/2024 - 01/2014
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2024 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 11/2023 - 06/2016
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 12/2022
2	ChemokinesIBA 01/2023 - 01/2017

Therapy/Procedure

64	Therapeutics 03/2024 - 09/2005
22	Drug Therapy (Chemotherapy) 04/2024 - 01/2011
13	Moxibustion 11/2023 - 06/2010
10	Lasers (Laser) 01/2022 - 06/2010
10	Transplantation 11/2020 - 01/2012
7	Liver Transplantation 01/2023 - 08/2005
7	Radiotherapy 01/2023 - 02/2016
7	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2012
5	Kidney Transplantation 01/2022 - 06/2012
4	Immunotherapy 01/2023 - 01/2021
3	Phototherapy (Light Therapy) 12/2022 - 02/2019
2	Gas Lasers 11/2023 - 08/2020